Northwest Biotherapeutics | NWBO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Agenus USD 18.74M 16.26M 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Celldex Therapeutics USD 47.45M 11.72M 2026-06
Eisai JPY 245.42B 56.22B 2026-03
Merck USD 6.85B 1.52B 2026-06
Northwest Biotherapeutics USD 4.56M 244K 2025-09
Pfizer USD 976M 727M 2026-06
Plus Therapeutics USD 2.37M 656K 2026-06
Roche Holding CHF 7.55B 579M 2025-06